Holen Sie sich die Stockscreener-App
7.59
2.71%
0.20
Handel nachbörslich:
7.56
-0.03
-0.40%
Schlusskurs vom Vortag:
$7.39
Offen:
$7.48
24-Stunden-Volumen:
3.45M
Relative Volume:
0.83
Marktkapitalisierung:
$1.43B
Einnahmen:
$42.73M
Nettoeinkommen (Verlust:
$-204.38M
KGV:
-6.2603
EPS:
-1.2124
Netto-Cashflow:
$-189.73M
1W Leistung:
+6.90%
1M Leistung:
-41.71%
6M Leistung:
-6.18%
1J Leistung:
+20.86%
1-Tages-Spanne:
$7.30
$7.74
1-Wochen-Bereich:
$6.97
$7.74
52-Wochen-Spanne:
$5.02
$21.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Compare WVE vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
7.59 | 1.39B | 42.73M | -204.38M | -189.73M | -1.2124 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-05 | Eingeleitet | BofA Securities | Buy |
| 2025-12-12 | Bestätigt | Wedbush | Outperform |
| 2025-12-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-04 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-28 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-16 | Eingeleitet | Citigroup | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Wedbush | Outperform |
| 2025-02-25 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
| 2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Eingeleitet | Raymond James | Outperform |
| 2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Eingeleitet | Guggenheim | Buy |
| 2019-07-15 | Eingeleitet | Cowen | Market Perform |
| 2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-08-07 | Eingeleitet | Stifel | Buy |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-07 | Eingeleitet | Jefferies | Buy |
| 2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Wave Life Sciences plans redomicile from Singapore to U.S. - Investing.com
Wave Life Sciences Plans Redomiciling to Delaware Corporation - TipRanks
Wave Life Sciences (NASDAQ: WVE) proposes one-for-one redomiciliation to Delaware parent - Stock Titan
Wave Life Sciences plans redomicile from Singapore to U.S. By Investing.com - Investing.com Canada
Wave Life Sciences (Nasdaq: WVE) sets tax-free U.S. redomiciliation - Stock Titan
Wave Life Sciences seeks Delaware move to cut compliance costs - Stock Titan
Jefferies Maintains “Buy” Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning - MSN
WVE Maintains Rating by HC Wainwright & Co. -- Price Target Lowe - GuruFocus
WVE Maintains Rating by HC Wainwright & Co. -- Price Target Lowered to $18 - GuruFocus
Wave Life Sciences (WVE) price target decreased by 20.34% to 28.29 - MSN
RBC Capital Maintains Outperform Rating on Wave Life Sciences (WVE) - Yahoo Finance
WAVE Life Sciences (NASDAQ:WVE) Downgraded to "Strong Sell" Rating by Wall Street Zen - MarketBeat
Q1 2025 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus
WVE Stock Price, Quote & Chart | WAVE LIFE SCIENCES LTD (NASDAQ:WVE) - ChartMill
Wave Life Sciences plunges after early-stage data for obesity therapy - MSN
Wave Life Sciences Ltd. R (1U5.DU) Q1 FY2025 earnings call transcript - Yahoo Finance
RBC Capital Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $15 - Moomoo
RBC Capital Adjusts Wave Life Sciences PT to $15 From $27, Maintains Outperform Rating - Moomoo
Wave Life Sciences Ltd. (WVE) PT increased to $52 at Canaccord following pipeline review - MSN
WAVE Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Wave Life Sciences (WVE) Is Up 14.4% After Phase 1 Data On Long‑Acting Obesity Drug WVE‑007 - Sahm
Aug Momentum: Is Wave Life Sciences Ltd gaining market shareTrade Analysis Report & Weekly Breakout Stock Alerts - baoquankhu1.vn
A Look At Wave Life Sciences (WVE) Valuation After INLIGHT Phase 1 Obesity Data Disappoints Investors - simplywall.st
Growth Recap: Is Wave Life Sciences Ltd gaining market share2026 Drop Watch & Intraday High Probability Setup Alerts - baoquankhu1.vn
Wave Life Sciences shares plunge 30% despite encouraging obesity trial results - MSN
Wave Life Sciences Ltd. (WVE) stock price, news, quote and history - Yahoo Finance Singapore
WVE.O PE Ratio & Valuation, Is WVE.O Overvalued - Intellectia AI
WVE.O Forecast — Price Prediction for 2026. Should I Buy WVE.O? - Intellectia AI
Wave Life Sciences Ltd. (WVE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Gold Royalty, Wave Life Sciences, and More Stocks See Action From Activist Investors -- Barrons.com - moomoo.com
WVE.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
WVE.O Technical Analysis & Stock Price Forecast - Intellectia AI
Wave Life Sciences’ Weight Loss Drug Phase 1 Clinical Data Triggers Stock Volatility, Yet Differentiated Path Still Shows Promise - NAI500
Wave Life Sciences (WVE) Surges 9.5%: Is This an Indication of Further Gains? - qz.com
Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007 - Investing News Network
Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Cuts Target Price to $13 - Moomoo
WVE Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
JPMorgan Chase & Co. Has $6.30 Million Position in WAVE Life Sciences Ltd. $WVE - MarketBeat
WVE posts interim data from phase I study on WVE-007, stock tanks - MSN
WAVE Life Sciences (NASDAQ:WVE) Shares Gap UpTime to Buy? - MarketBeat
Wave Life Sciences Stock (WVE) Opinions on INLIGHT Trial Data - Moomoo
Wave Life Sciences Obesity Data Highlights Visceral Fat Focus Over Weight Loss - Yahoo Finance
[SCHEDULE 13D/A] Wave Life Sciences Ltd. Amended Major Shareholder Report - Stock Titan
RA Capital boosts Wave Life Sciences (NASDAQ: WVE) stake with 8.8M-share open-market buy - Stock Titan
Wave Life Sciences Ltd. (WVE) PT Increased to $52 at Canaccord Following Pipeline Review - Insider Monkey
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):